CANCELED: Hilliard Seigler Melanoma Consortium
Note: “We regret to inform you the 2020 Consortium has been canceled. We are planning to have the consortium on Friday May 14, 2021 and look forward to seeing you then. The Duke melanoma team wishes you and your family the best during these times.”
This year's annual conference of the Melanoma Consortium will be held from 8:15 a.m. to 12:30 p.m. on Thursday, May 14, 2020 at Duke South Amphitheater.
Starting this year, the consortium will formally be known as the Hilliard Seigler Duke Melanoma Consortium, the "Seig DMC."
In 1988, Hilliard Seigler, MD, organized the first Duke Melanoma Consortium. For nearly 30 years patients, families, and friends have come to Durham on a yearly basis to learn about advances in melanoma. Seigler was a practicing melanoma surgeon at Duke University for over 40 years. He led groundbreaking research efforts in melanoma and dedicated his career to the care of patients and families with melanoma.
The consortium was originally formed by a group of laymen, physicians and researchers who have a common interest in melanoma research and has a two-fold purpose:
- To learn about innovative basic and clinical melanoma research programs both nationally and internationally.
- To learn about basic and clinical melanoma programs at Duke University Medical Center.
Duke speakers include director of the Melanoma Disease Group, April Salama, MD, and co-director Georgia Beasley, MD; Allan Kirk, MD, PhD (chair of the Department of Surgery); Meenal Kheterphal, MD (assistant professor of Dermatology); Rami Al-Rohil, MD, MBBS (assistant professor of Pathology); Paul Mosca, MD, PhD (associate professor of Surgery); Nellie Farrow, MD (General Surgery resident); and Brent Hanks, MD, PhD (assistant professor of Medicine, Medical Oncology); and Michael Kastan, MD, PhD (executive director of Duke Cancer Institute).
Stergios Moschos, MD, associate professor of Medicine, Hematology/Oncology, Melanoma, of UNC-Chapel Hill will also speak.
Dan Coit, MD, professor of Surgery at Weill Cornell Medical College and co-Leader of the Melanoma Disease Management Team and surgical oncologist at Memorial Sloan Kettering Cancer Center, will be the keynote speaker.